These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22134426)

  • 21. [Activated protein C--recent addition to therapy of sepsis].
    Gårdlund B; Sjölin J
    Lakartidningen; 2003 Jun; 100(26-27):2292-6. PubMed ID: 12872375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant human activated protein C sentenced to the death of a thousand cuts?
    O'Brien JM
    Crit Care Med; 2007 Jun; 35(6):1609-10. PubMed ID: 17522532
    [No Abstract]   [Full Text] [Related]  

  • 24. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 25. What is the role of recombinant activated protein C in the management of sepsis?
    Alvarado J; Castro R
    Medwave; 2016 Dec; 16(Suppl5):e6801. PubMed ID: 28032853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.
    Payen D; Sundin DP; Nelson DR; Williams MD
    Surgery; 2007 Sep; 142(3):426-7. PubMed ID: 17723900
    [No Abstract]   [Full Text] [Related]  

  • 27. Septic shock--evaluating another failed treatment.
    Wenzel RP; Edmond MB
    N Engl J Med; 2012 May; 366(22):2122-4. PubMed ID: 22616829
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticosteroids and human recombinant activated protein C for septic shock.
    Colin G; Annane D
    Clin Chest Med; 2008 Dec; 29(4):705-12, x. PubMed ID: 18954704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of activated protein C in a case of paediatric septic shock.
    Verre M; Barozzi E; Piccirillo M; Tancioni F; Tiburzi S; Varano M
    Minerva Pediatr; 2005 Dec; 57(6):429-32. PubMed ID: 16402015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing indications based on successful clinical trials in sepsis: a difficult exercise.
    Carlet J
    Crit Care Med; 2006 Feb; 34(2):525-9. PubMed ID: 16424736
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 32. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Rustige J
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698; author reply 1699-70. PubMed ID: 15273923
    [No Abstract]   [Full Text] [Related]  

  • 33. An opinion too far--the campaign against the Surviving Sepsis Campaign.
    Barie PS
    Surg Infect (Larchmt); 2006 Dec; 7(6):485-8. PubMed ID: 17233565
    [No Abstract]   [Full Text] [Related]  

  • 34. Drotrecogin alpha (activated) in septic shock after lung transplant.
    Feltracco P; Rea F; Ori C
    J Heart Lung Transplant; 2008 Jul; 27(7):815. PubMed ID: 18582817
    [No Abstract]   [Full Text] [Related]  

  • 35. [Activated protein C in patients with septic shock: pro].
    Marx G
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2370. PubMed ID: 21082530
    [No Abstract]   [Full Text] [Related]  

  • 36. Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery.
    Pappalardo F; Cristallo E; Franco A; Antonioli G; Zangrillo A
    Eur J Anaesthesiol; 2007 Mar; 24(3):294-5. PubMed ID: 17054810
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activated protein C in patients with septic shock: contra].
    Graf J
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2371. PubMed ID: 21082531
    [No Abstract]   [Full Text] [Related]  

  • 38. Drotrecogin alpha (activated) in neonatal septic shock.
    Frommhold D; Birle A; Linderkamp O; Zilow E; Pöschl J
    Scand J Infect Dis; 2005; 37(4):306-8. PubMed ID: 15804668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature.
    Funk DJ; Palma Vargas J; Tuttle-Newhall J; Moretti EW
    Transpl Infect Dis; 2011 Dec; 13(6):592-7. PubMed ID: 21794040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human activated protein C as a therapy for severe sepsis: lessons learned?
    Opal SM; LaRosa SP
    Am J Respir Crit Care Med; 2013 May; 187(10):1041-3. PubMed ID: 23675711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.